Literature DB >> 28636861

Timing of Metastasis in Breast Cancer.

Robert S Schwartz1, John K Erban1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28636861     DOI： 10.1056/NEJMcibr1701388

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  24 in total

1.  Long non-coding RNA TDRG1 facilitates cell proliferation, migration and invasion in breast cancer via targeting miR-214-5p/CLIC4 axis.

Authors:  Yanrong Lv; Ke Dong; Haidong Gao
Journal:  Cancer Biol Ther       Date:  2021-04-06       Impact factor: 4.742

2.  Overexpression of ING3 is associated with attenuation of migration and invasion in breast cancer.

Authors:  Huimeng Li; Hengyu Zhang; Xin Tan; Dequan Liu; Rong Guo; Maohua Wang; Yiyin Tang; Kai Zheng; Wenlin Chen; Hongwan Li; Mingjian Tan; Ke Wang; Rui Liu; Shicong Tang
Journal:  Exp Ther Med       Date:  2021-05-02       Impact factor: 2.447

Review 3.  Renewed considerations on the utility (or the futility) of hepatic resections for breast cancer liver metastases.

Authors:  Gian Luca Grazi
Journal:  Hepatobiliary Surg Nutr       Date:  2021-01       Impact factor: 8.265

4.  Long noncoding RNA LINC01089 predicts clinical prognosis and inhibits cell proliferation and invasion through the Wnt/β-catenin signaling pathway in breast cancer.

Authors:  Hongfan Yuan; Yi Qin; Beilei Zeng; Yixiao Feng; Yunhai Li; Tingxiu Xiang; Guosheng Ren
Journal:  Onco Targets Ther       Date:  2019-06-21       Impact factor: 4.147

Review 5.  Moving Breast Cancer Therapy up a Notch.

Authors:  Erik W J Mollen; Jonathan Ient; Vivianne C G Tjan-Heijnen; Liesbeth J Boersma; Lucio Miele; Marjolein L Smidt; Marc A G G Vooijs
Journal:  Front Oncol       Date:  2018-11-20       Impact factor: 6.244

6.  Prognostic value of biomarkers EpCAM and αB-crystallin associated with lymphatic metastasis in breast cancer by iTRAQ analysis.

Authors:  Liang Zeng; Xiyun Deng; Jingmin Zhong; Li Yuan; Xiaojun Tao; Sai Zhang; Yong Zeng; Guangchun He; Pingping Tan; Yongguang Tao
Journal:  BMC Cancer       Date:  2019-08-23       Impact factor: 4.430

7.  Risk factors for axillary lymph node metastases in clinical stage T1-2N0M0 breast cancer patients.

Authors:  Yuanxin Zhang; Ji Li; Yuan Fan; Xiaomin Li; Juanjuan Qiu; Mou Zhu; Hongjiang Li
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.889

8.  Circulating Tumor Cell Clusters Are Frequently Detected in Women with Early-Stage Breast Cancer.

Authors:  Carolina Reduzzi; Serena Di Cosimo; Lorenzo Gerratana; Rosita Motta; Antonia Martinetti; Andrea Vingiani; Paolo D'Amico; Youbin Zhang; Marta Vismara; Catherine Depretto; Gianfranco Scaperrotta; Secondo Folli; Giancarlo Pruneri; Massimo Cristofanilli; Maria Grazia Daidone; Vera Cappelletti
Journal:  Cancers (Basel)       Date:  2021-05-13       Impact factor: 6.639

Review 9.  Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis.

Authors:  Yixiao Feng; Mia Spezia; Shifeng Huang; Chengfu Yuan; Zongyue Zeng; Linghuan Zhang; Xiaojuan Ji; Wei Liu; Bo Huang; Wenping Luo; Bo Liu; Yan Lei; Scott Du; Akhila Vuppalapati; Hue H Luu; Rex C Haydon; Tong-Chuan He; Guosheng Ren
Journal:  Genes Dis       Date:  2018-05-12

10.  Identification of a Six-Immune-Related Long Non-coding RNA Signature for Predicting Survival and Immune Infiltrating Status in Breast Cancer.

Authors:  Zheng Li; Yaming Li; Xiaolong Wang; Qifeng Yang
Journal:  Front Genet       Date:  2020-07-07       Impact factor: 4.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.